Diaceutics PLC

Rentabilité sur six mois: -0.0146%
Rendement en dividendes: 0%
Secteur: Healthcare

1.37 $

-0.0002 $ -0.0146%
1.37 $
1.37 $

paper.min_max_per_year

Calendrier des promotions Diaceutics PLC

À propos de l'entreprise Diaceutics PLC

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.

plus de détails
The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Paramètres de base

Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
gbp
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 3.82 4
P/BV 2.22 7
P/E 108.67 1
Efficacité
Nom Signification Grade
ROA -3.77 0
ROE -4.28 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 0.7109 9
Debt/Ratio 0.026 10
Debt/Equity 0.1363 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 76.3 8
Rentabilité Ebitda, % -0.6955 0
Rentabilité EPS, % -170.03 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 1.37 $ 0 $ 0 $ -0.01 % 0 % 0 %
common.calendar.number_days.7d 1.37 $ 0 $ 0 $ -0.01 % 0 % 0 %
common.calendar.number_days.30d 1.37 $ 1.37 $ 1.37 $ -0.01 % 0 % 0 %
common.calendar.number_days.90d 1.37 $ 1.37 $ 1.37 $ -0.01 % 0 % 0 %
common.calendar.number_days.180d 1.37 $ 1.37 $ 1.37 $ -0.01 % 0 % 0 %
common.calendar.number_days.1y 1.37 $ 1.37 $ 1.37 $ 0 % 0 % 0 %
common.calendar.number_days.3y 1.38 $ 1.05 $ 1.38 $ -0.97 % 0 % 0 %
common.calendar.number_days.5y 0 $ 1.05 $ 2.3 $ 0 % 0 % 0 %
common.calendar.number_days.10y 0 $ 1.05 $ 2.3 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 1.37 $ 1.37 $ 1.37 $ -0.01 % 0 % 0 %

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Jordan Clark Chief Data Officer? N/A
Ms. Susanne Munksted Chief Precision Medicine Officer N/A
Ms. Jillian Beggs Chief Commercial Officer
Madeline Brown VP & Chief of Staff
Ms. Sally Craig Company Secretary

Informations sur l'entreprise

Adresse: United Kingdom, Belfast, Building Two - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.diaceutics.com